Bio-Rad Laboratories, Inc. Class A Common Stock (BIO)

Financing Cash Flow

-$121.10M

TTM · Period ending: · USD

BIO logo

BIO Financing Cash Flow

Latest reported-$121.10M
BIO TTM Cash from Financing ($7.40M → -$121.10M)
High-resolution chart · PNG

BIO financing cash flow history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Bio-Rad Laboratories, Inc. Class A Common Stock Financing Cash Flow — Trailing twelve months (TTM) (USD)
Period endingFinancing Cash Flow (USD)
-121,100,000
-229,500,000
-283,200,000
-312,748,000
-356,234,000
-316,521,000
-218,800,000
-393,172,000
-323,784,000
-429,935,000
-425,647,000
-311,646,000
-293,820,000
-212,408,000
973,576,000
1,064,830,000
1,058,020,000
1,182,211,000
-55,429,000
-481,948,000
-465,927,000
-471,771,000
-523,041,000
-105,940,000
-110,870,000
-123,536,000
-22,758,000
-64,978,000
-62,663,000
-49,034,000
-48,680,000
1,899,000
1,235,000
2,183,000
341,000
-406,000
5,331,000
9,435,000
9,020,000
9,919,000
9,145,000
9,170,000
8,581,000
8,478,000
8,121,000
7,868,000
11,689,000
11,832,000
-299,263,000
-300,781,000
-311,697,000
-311,950,000
-67,000
1,443,000
12,588,000
7,340,000
6,842,000
4,902,000
-213,560,000
9,695,000
10,671,000
12,969,000
228,745,000
8,893,000
7,019,000
297,009,000
293,933,000
294,185,000
293,760,000
1,499,000
6,331,000
-15,631,000
-13,129,000
-11,926,000
-7,450,000
13,190,000
12,982,000
14,731,000
10,162,000
6,349,000
2,733,000
1,191,000
1,290,000
204,235,000
195,066,000
196,046,000
193,227,000
-5,401,000
112,694,000
110,557,000
108,169,000
71,441,000
-45,980,000
-68,614,000
-78,204,000
-55,491,000
-46,860,000
-32,579,000
-20,162,000
-11,056,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.